Q: IF I ENROL IN THE STUDY WILL I DEFINITELY RECEIVE TF-CRM107?
A: No. The Tf-CRM107 Phase III study is randomised. This means that 2 out of 3 patients will receive the trial drug, whilst 1 out of 3 will receive best standard of care; therefore there is no guarantee that any single patient will receive Tf-CRM107.



Back to FAQs